🇺🇸 FDA
Patent

US 7807781

Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

granted A61KA61K38/57A61K45/06

Quick answer

US patent 7807781 (Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections) held by The Regents of the University of Colorado expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/57, A61K45/06